Baseline tumor Lipiodol uptake after transarterial chemoembolization for hepatocellular carcinoma: identification of a threshold value predicting tumor recurrence
The aim of the study was to evaluate the association between baseline Lipiodol uptake in hepatocellular carcinoma (HCC) after transarterial chemoembolization (TACE) with early tumor recurrence, and to identify a threshold baseline uptake value predicting tumor response.
Main Authors: | Matsui Yusuke, Horikawa Masahiro, Jahangiri Noudeh Younes, Kaufman John A., Kolbeck Kenneth J., Farsad Khashayar |
---|---|
Format: | Article |
Language: | English |
Published: |
Sciendo
2017-07-01
|
Series: | Radiology and Oncology |
Subjects: | |
Online Access: | https://doi.org/10.1515/raon-2017-0030 |
Similar Items
-
A Rare Case of Empyema Developed after Transarterial Chemoembolization for Hepatocellular Carcinoma
by: Young Keun Sur, et al.
Published: (2015-01-01) -
Feasibility and Techniques of Securing 3D-Safety Margin in Superselective Transarterial Chemoembolization to Improve Local Tumor Control for Small Hepatocellular Carcinoma: An Intend-to-Treat Analysis
by: Ching Charoenvisal, et al.
Published: (2021-01-01) -
Initial Transarterial Chemoembolization (TACE) Using HepaSpheres 20–40 µm and Subsequent Lipiodol TACE in Patients with Hepatocellular Carcinoma > 5 cm
by: Su Min Cho, et al.
Published: (2021-04-01) -
The effect of lipiodol deposition in HCC after TACE on the necrosis range of PMCT
by: Sun HL, et al.
Published: (2017-08-01) -
Adjuvant Transarterial Chemoembolization Following Curative-Intent Hepatectomy Versus Hepatectomy Alone for Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
by: Stepan M. Esagian, et al.
Published: (2021-06-01)